業績

2023年

* corresponding author; # equally contributed author

  1. Aldoghachi, A.F., Yanagisawa, D.#, Pahrudin Arrozi, A., Abu Bakar, Z.H., Taguchi, H., Ishigaki, S., Morino, K., and Tooyama, I#. (2023). Fluorinated curcumin derivative (Shiga-Y6) modulates the level of thioredoxin-interacting protein (TXNIP) in a mouse model of diabetes. Biochem. Biophys. Res. Commun. 694, 149392. 10.1016/j.bbrc.2023.149392.

  2. Takeuchi T, Maeta K, Xin D, Oe Y, Takeda A, Inoue M, Nagano S, Fujihara T, Matsuda S, Ishigaki S, Sahashi K, Minakawa E, Mochizuki H, Neya M, Sobue G and Nagai Y. Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice. Mol Ther Nucl Acids. 31:353-366, 2023.

  3. Abu Bakar ZH, Bellier JP, Wan Ngah WZ, Yanagisawa D, Mukaisho KI, Tooyama I. Optimization of 3D Immunofluorescence Analysis and Visualization Using IMARIS and MeshLab. Cells, 12:218, 2023.

  4. Azlan UK, Khairul Annuar NA, Mediani A, Aizat WM, Damanhuri HA, Tong X, Yanagisawa D, Tooyama I, Wan Ngah WZ, Jantan I, Hamezah HS. An insight into the neuroprotective and anti-neuroinflammatory effects and mechanisms of Moringa oleifera. Frontiers in Pharmacology, 13:1035220, 2023.